PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 21, 2026Proteomes0 citationsOpen Access

Emergence of Catalytic Activity in VRK3: Phosphoproteomic Insights into the Regulatory Network of a Former Pseudokinase

View Full Paper
ASAyadathil SujinaAFAmal FahmaSSSuhail Subair

Key Points

  • The aim is to explore the phosphoregulatory network influencing VRK3 phosphorylation and its functional implications.
  • Conducted large-scale phosphoproteomic data integration.
  • Combined profiling and differential phosphorylation from 115 mass spectrometry studies.
  • Identified 32 high-confidence phosphorylation sites on VRK3.
  • Discovered significant phosphorylation sites at VRK3 (S59), (S82), and (S83).
  • Identified 33 potential upstream kinases regulating VRK3 activity.
  • Uncovered interactions with proteins involved in ERK, Hippo, and GPCR pathways.

Abstract

Vaccinia-Related Kinase 3 (VRK3) is increasingly recognized as a crucial signaling modulator in both normal and pathological processes. This kinase was long thought of as a catalytically inactive pseudokinase, until recently it was established to phosphorylate Barrier to Autointegration Factor (BAF) proteins through its extracatalytic domain. VRK3 regulates diverse cellular pathways through scaffold interactions and context-dependent phosphorylation. This review is centered around the phosphoregulatory network that modulates VRK3 phosphorylation with implications in its abundance and function. A large-scale phosphoproteomic data integration was performed by combining phosphoproteomics profiling and differential phosphorylation from 115 mass spectrometry studies, identifying 32 high-confidence phosphorylation sites on VRK3. Notably, VRK3 (S59), (S82), and (S83) were predominantly observed highlighting plausible functional significance. These phosphorylation sites share 33 potential upstream kinases, and multiple interactor proteins, which in combination are known to regulate ERK, Hippo, and GPCR pathways. These insights advance the understanding of phosphorylation control by kinases and highlight opportunities to target VRK3-associated networks for therapeutic intervention in diseases such as glioma and liver cancer.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sujina et al. (2026) studied this question.

synapsesocial.com/papers/69be356f6e48c4981c673a42https://doi.org/10.3390/proteomes14010014
Ask AI
Helpful
Bookmark
Share
View Full Paper